Responsibility for administration of this program will reside in the Administrative core (Core C), directed by the overall PI of the program, Dr. Christopher B. Newgard, who will devote 5% of his time to this effort. He will be assisted in this role by James R. McCurdy, Business Manager of the Sarah W. Stedman Nutrition and Metabolism Center at Duke, and Ms. Brenda Aston, Chief Administrator of the Advanced Imaging Center at UTSW. This team will work closely with the project and core Pis in preparation of yearly progress reports, monitoring of personnel changes that occur during the course of the program, and oversight of the program budget, including yearly summaries of expenditures. Core C will also be responsible for assuring that the program is in compliance with institutional standards for human and animal research, including the timely submission of protocols to the relevant institutional review committees. A travel budget has been requested in Core C to allow four face-to-face meetings of the UTSW and Duke Pis per year, and for yearly meetings of the Scientific Advisory Board. Dr. Newgard and his staff will plan and coordinate those meetings. In the unlikely event that Dr. Newgard is rendered unable to fulfill his duties as Principal Investigator of this Program Project for any reason. Dr. Sherry will take full responsibility for completion of the program, and will work closely with the other investigators and senior administrative personnel at Duke and UTSWMC to ensure continued coordination of effort and delivery of the program milestones.
The administrative core of this progam will provide oversight that ensures timely achievement of the core goals of the program, and will optimize communication between team members. It will also monitor all budgetary allocations, time commitment of key personnel, and progress reporting requirements.
|Shantavasinkul, Prapimporn Chattranukulchai; Muehlbauer, Michael J; Bain, James R et al. (2018) Improvement in insulin resistance after gastric bypass surgery is correlated with a decline in plasma 2-hydroxybutyric acid. Surg Obes Relat Dis 14:1126-1132|
|McGarrah, Robert W; Crown, Scott B; Zhang, Guo-Fang et al. (2018) Cardiovascular Metabolomics. Circ Res 122:1238-1258|
|Fisher-Wellman, Kelsey H; Davidson, Michael T; Narowski, Tara M et al. (2018) Mitochondrial Diagnostics: A Multiplexed Assay Platform for Comprehensive Assessment of Mitochondrial Energy Fluxes. Cell Rep 24:3593-3606.e10|
|Jin, Eunsook S; Lee, Min Hee; Murphy, Rebecca E et al. (2018) Pentose phosphate pathway activity parallels lipogenesis but not antioxidant processes in rat liver. Am J Physiol Endocrinol Metab 314:E543-E551|
|Ren, Jimin; Shang, Ty; Sherry, A Dean et al. (2018) Unveiling a hidden 31 P signal coresonating with extracellular inorganic phosphate by outer-volume-suppression and localized 31 P MRS in the human brain at 7T. Magn Reson Med 80:1289-1297|
|An, Jie; Wang, Liping; Patnode, Michael L et al. (2018) Physiological mechanisms of sustained fumagillin-induced weight loss. JCI Insight 3:|
|Peterson, Brett S; Campbell, Jonathan E; Ilkayeva, Olga et al. (2018) Remodeling of the Acetylproteome by SIRT3 Manipulation Fails to Affect Insulin Secretion or ? Cell Metabolism in the Absence of Overnutrition. Cell Rep 24:209-223.e6|
|White, Phillip J; McGarrah, Robert W; Grimsrud, Paul A et al. (2018) The BCKDH Kinase and Phosphatase Integrate BCAA and Lipid Metabolism via Regulation of ATP-Citrate Lyase. Cell Metab 27:1281-1293.e7|
|Jin, Eunsook S; Browning, Jeffrey D; Murphy, Rebecca E et al. (2018) Fatty liver disrupts glycerol metabolism in gluconeogenic and lipogenic pathways in humans. J Lipid Res 59:1685-1694|
|Newgard, Christopher B (2017) Metabolomics and Metabolic Diseases: Where Do We Stand? Cell Metab 25:43-56|
Showing the most recent 10 out of 181 publications